The FDA has proposed removing the boxed warning for menopausal hormone therapy, focusing on local estrogen use and ...

Controversy and confusion have shrouded hormone replacement therapy (HRT)—which involves using estrogen to help alleviate ...

Menopause, the natural cessation of periods due to lower hormone levels, typically occurs between the ages of 45 and 55. The ...

A growing body of research suggests testosterone replacement therapy can alleviate menopausal symptoms such as a decrease in ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to ...

The hormonal replacement therapy market size is calculated at USD 25.88 billion in 2025 and is expected to reach around USD 46.32 billion by 2034, growing at a CAGR of 6.68% for the forecasted period.

Prescriptions for hormone replacement therapy plummeted after a warning label was added to the menopause treatments decades ...

Hormone replacement therapy (HRT) or menopausal hormone therapy (MHT) are treatments to mediate symptoms of menopause.

The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...

A study led by researchers at Queen Mary University of London has found that hormone replacement therapy (HRT) may help ...

A study led by researchers at Queen Mary University of London has found that hormone replacement therapy (HRT) may help ...